IP Library Granted Patent US 7,228,295
Granted Patent B2
US 7,228,295 · App. 10/164,053 · Granted Jun 5, 2007

Methods for selecting, developing and improving diagnostic tests for pregnancy-related conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,228,295
App. No.
10/164,053
Granted
Jun 5, 2007
Kind
B2
Abstract

Decision-support systems, such as neural networks, for assessing the risk of delivery within a predetermined time or the likelihood of preterm delivery are provided.

Claims (26)

1. A decision support system trained for assessing the risk of imminent delivery within in a predetermined time frame or the likelihood of preterm delivery.

2. The decision support system of claim 1 that comprises a neural network.

3. A computer readable medium, comprising the neural network of claim 2 .

4. A computer readable medium, comprising the decision support system of claim 1 .

5. The decision support system of claim 1 that assesses the likelihood of preterm delivery.

6. The decision support system of claim 5 that is a neural network.

7. The decision support system of claim 1 that assesses the risk of delivery within in a predetermined time.

8. The decision support system of claim 7 , wherein the time is 7 days.

9. The decision support system of claim 8 that is a neural network.

10. The decision support system of claim 8 , wherein input variables comprise variables containing at least three and up to all of the responses to the following queries: Ethnic Origin Caucasian; Uterine contractions with or without pain; Parity-abortions; vaginal bleeding at time of sampling; uterine contractions per hour; and No previous pregnancies.

11. The decision support system of claim 10 that is a neural network.

12. The decision support system of claim 10 , wherein the variables further comprise the results from one or more of a biochemical test that detects fetal fibronectin in cervico/vaginal samples, determines the level of a local inflammatory product protein in cervico/vaginal samples; or determines estriol or estretol in saliva.

13. The decision support system of claim 12 that is a neural network.

14. The decision support system of claim 7 , wherein the time is 14 days.

15. The decision support system of claim 14 that is a neural network.

16. The decision support system of claim 14 , wherein input variables comprise variables containing at least three and up to all of the responses to the following queries: Ethnic Origin Hispanic; Marital Status living with partner; Uterine contractions with or without pain; Cervical dilatation; Uterine contractions per hour; and No previous pregnancies.

17. The decision support system of claim 16 that is a neural network.

18. The decision support system of claim 16 , wherein the variables further comprise the results from one or more of a biochemical test that detects fetal fibronectin in cervico/vaginal samples, determines the level of a local inflammatory product protein in cervico/vaginal samples; or determines estriol or estretol in saliva.

19. The decision support system of claim 18 that is a neural network.

20. The decision support system of claim 7 that is a neural network.

21. The decision support system of claim 1 , wherein the risk of delivery before 35 weeks is assessed.

22. The decision support system of claim 21 that is a neural network.

23. The decision support system of claim 21 , wherein input variables comprise variables containing at least three and up to all of the responses to the following queries: Ethnic Origin Caucasian; Marital Status living with partner; EGA by sonogram; EGA at sampling; estimated date of delivery by best; cervical dilatation (CM); parity-preterm; vaginal bleeding at time of sampling; cervical consistency at time of sampling; and previous pregnancy without complication is provided.

24. The decision support system of claim 23 that is a neural network.

25. The decision support system of claim 23 , wherein the variables further comprise the results from one or more of a biochemical test that detects fetal fibronectin in cervico/vaginal samples, determines the level of a local inflammatory product protein in cervico/vaginal samples; or determines estriol or estretol in saliva.

26. The decision support system of claim 25 that is a neural network.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →